Direct oral anticoagulants’ positive effects on cancer-associated VTE
DOAC use may not be approved in VTE cancer patients, but GlobalData KOLs share that these drugs are becoming commonplace as a treatment.
DOAC use may not be approved in VTE cancer patients, but GlobalData KOLs share that these drugs are becoming commonplace as a treatment.
What's Your Reaction?
